Retail sale of pharmaceutical products
VIVIBENE AS
Revenue 2025
NOK 3.8m
Operating profit
NOK −214,000
Equity
NOK 668,000
Incorporated
2019
Share capital
NOK 650,000
Key figures · 2025
Current ratio
3.81
Equity ratio
76.2%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -5.7% | |
| Net margin (%%) | -6.2% | |
| Return on assets (%%) | -24.4% | |
| Likviditet | ||
| Current ratio | 3.81 | |
| Working capital | 584k | |
| Soliditet | ||
| Equity ratio (%%) | 76.2% | |
| Debt-to-equity ratio | 0.31 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.